GC Biopharma Supports New Insights into Education, Safety, and Patient Outcomes in Ig Therapy Care at the 2025 IgNS Annual Meeting
PR Newswire —
Sponsorship of educational satellite symposium and the support of data analysis and publication of the 2025 IgNS Patient 360 Longitudinal Survey results reflect GC Biopharma's commitment to advancing IVIG safety, education, and patient-centered care TEANECK, N.J., Nov. 6, 2025...